AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard,…
| Price | $1.11 |
|---|---|
| Market cap | $5.71M |
| Sector | Consumer Defensive |
| Industry | Agricultural Farm Products |
| Exchange | NASDAQ |
| 52-week range | 0.774-2.95 |
| Beta | 1.46 |
Explore AQB's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.